Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) saw a significant decline in short interest in July. As of July 15th, there was short interest totaling 19,796 shares, a decline of 40.4% from the June 30th total of 33,197 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average trading volume of 68,010 shares, the short-interest ratio is currently 0.3 days.
Analysts Set New Price Targets
Separately, Weiss Ratings cut shares of Baird Medical Investment from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, May 8th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.
Get Our Latest Stock Analysis on BDMD
Hedge Funds Weigh In On Baird Medical Investment
Baird Medical Investment Stock Up 1.5%
Shares of NASDAQ:BDMD traded up $0.01 during mid-day trading on Thursday, hitting $1.04. 6,960 shares of the company traded hands, compared to its average volume of 980,135. Baird Medical Investment has a 12-month low of $0.76 and a 12-month high of $3.75. The stock has a 50-day moving average price of $1.21 and a two-hundred day moving average price of $1.53.
About Baird Medical Investment
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Further Reading
- Five stocks we like better than Baird Medical Investment
- DoorDash’s Drone Certification Could Reshape Its Delivery Margins
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
